VPS39 Antibodies

Santa Cruz Biotechnology delivers a wide array of VPS39 monoclonal antibodies for research focused on understanding VPS39's role in cellular processes. VPS39 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VPS39 functions as a key component of the HOPS complex, which is essential for the fusion of late endosomes and lysosomes, playing a critical role in intracellular trafficking and degradation of cellular components. VPS39's function is vital for maintaining cellular homeostasis and regulating autophagy, making it a significant target for studies related to neurodegenerative diseases and cancer. Investigating VPS39 can provide valuable insights into the mechanisms of cellular transport and its implications in various pathological conditions. Researchers can explore VPS39's involvement in endosomal trafficking pathways and its potential therapeutic applications. Understanding VPS39's role in autophagy regulation may lead to new therapeutic strategies for treating various diseases. VPS39 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance their understanding of cellular trafficking mechanisms and contribute to breakthrough discoveries in cell biology and disease treatment.